Case number 1:20-cv-00922
Arbor Pharmaceuticals, LLC et al v. Lupin Limited et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Apr 18, 2022 | 106 | SO ORDERED (2) Docket Text: SO ORDERED re [105] Stipulation of Dismissal without Prejudice. ***Civil Case Terminated. Signed by Judge Maryellen Noreika on 4/18/2022. (dlw) |
| Apr 18, 2022 | 107 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s). (Attachments: # (1) Stipulation of dismissal)(mdb) |
| Apr 18, 2022 | 107 | Stipulation of dismissal (2) |
| Apr 14, 2022 | 105 | Stipulation of Dismissal (3) Docket Text: STIPULATION of Dismissal Without Prejudice by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Silver, Daniel) |
| Apr 8, 2022 | 104 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Lupin Limited and Lupin Pharmaceuticals, Inc.'s Notice Pursuant to 35 U.S.C. § 282 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Apr 4, 2022 | N/A | Case No Longer Referred to Mediation (0) Docket Text: CASE NO LONGER REFERRED to Chief Magistrate Judge Thynge for the purpose of exploring ADR. Pursuant to the Court's Standing Order No. 2022-2, dated March 14, 2022, "[u]nless otherwise directed by the Court, Magistrate Judges will no longer engage in alternative dispute resolution of patent and securities cases." See also 28 U.S.C. § 652(b). (Taylor, Daniel) |
| Mar 31, 2022 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [103] STIPULATION TO EXTEND TIME for Expert Depositions to April 15, 2022 (Set/Reset Scheduling Order Deadlines: Expert Discovery due by 4/15/2022). ORDERED by Judge Maryellen Noreika on 3/31/2022. (dlw) |
| Mar 30, 2022 | 103 | Stipulation to EXTEND Time (3) Docket Text: STIPULATION TO EXTEND TIME for Expert Depositions to April 15, 2022 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Mar 14, 2022 | 101 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) [HIGHLY CONFIDENTIAL-OUTSIDE COUNEL EYES ONLY] Reply Expert Report of Ivan T. Hofmann; (2) [HIGHLY CONFIDENTIAL-OUTSIDE COUNSEL EYES ONLY] Responsive Expert Report of Graham Buckton, Ph.D., D.SC. Regarding Invalidity of U.S. Patent No. 9,066,936; and (3) [HIGHLY CONFIDENTIAL-OUTSIDE COUNSEL EYES ONLY] Reply Expert Report of Jed Fisher, Ph.D. Regarding Invalidity of U.S. Patent Nos. 7,157,584 & 7,572,920 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Mar 14, 2022 | 102 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Reply Expert Report of Christian Schneich, Ph.D. filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Feb 17, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER RESETTING Scheduling Order Deadlines: IT IS HEREBY ORDERED that the 5-day Bench Trial in this matter is RESET for 5/9/2022 at 09:00 AM in Courtroom 4A before Judge Maryellen Noreika. The Pretrial Conference date remains the same (5/2/2022 at 10:00 AM). ORDERED by Judge Maryellen Noreika on 2/17/2022. (dlw) |
| Feb 16, 2022 | 99 | Letter (1) Docket Text: Joint Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. - re [96] Oral Order,,,,. (Silver, Daniel) |
| Feb 14, 2022 | 97 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [HIGHLY CONFIDENTIAL - OUTSIDE COUNSEL EYES ONLY] Responsive Expert Report of Graham Buckton, Ph.D., D.Sc. Regarding Infringement of U.S. Patent No. 9,066,936 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Feb 14, 2022 | 98 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Rebuttal Expert Report of Christian Schneich, Ph.D.; (2) Rebuttal Expert Report of Stephen G. Davies, Ph.D.; (3) Expert Report of Franz Messerli, M.D.; (4) Expert Report of Mohan Rao, Ph.D. filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Feb 9, 2022 | 95 | Letter (2) Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Request to Move the Trial Date Due to Scheduling Conflict. (Silver, Daniel) |
| Feb 9, 2022 | N/A | Oral Order (0) Docket Text: ORAL ORDER re [95] Letter - Having reviewed the parties' letter requesting the Court to adjourn the current May 16, 2022 trial date until mid-July in light of the participation of Plaintiffs' counsel in a trial in West Virginia the week of May 23, 2022, IT IS HEREBY ORDERED that the parties' request is DENIED. Trial in this matter was set on October 19, 2020, before the trial date was set in the Northern District of West Virginia action. Moreover, as the parties have already been informed, the Court's calendar cannot accommodate a request to move the trial to July. Nor can the Court agree to such a delay in light of the scheduled November 2022 end of the thirty-month stay. If the parties wish, however, the Court is willing to move the trial a week earlier to begin on May 9, 2022. On or before February 16, 2022, the parties shall jointly advise the Court on which date they would like to proceed to trial, May 16 or May 9, 2022. ORDERED by Judge Maryellen Noreika on 2/9/2022. (dlw) |
| Jan 10, 2022 | 93 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of the (1) [HIGHLY CONFIDENTIAL] Expert Report of Graham Buckton, Ph.D., D.Sc. Regarding the Validity of U.S. Patent No. 9,066,936; (2) [HIGHLY CONFIDENTIAL] Expert Report of Jed Fisher, Ph.D.; and (3) [HIGHLY CONFIDENTIAL] Declaration of Nandkumar G. Bhilare, Ph.D. filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jan 10, 2022 | 94 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Expert Report of Christian Schneich, Ph.D. Regarding Defendant Lupin's Infringement and (2) Expert Report of David E. Bugay, Ph.D. filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Dec 2, 2021 | N/A | Oral Order (0) Docket Text: ORAL ORDER: As a result of today's teleconference, IT IS ORDERED THAT counsel for defendant shall send a joint email to Judge Thynge, and her law clerk Daniel Taylor (daniel_taylor@ded.uscourts.gov), by COB Eastern Time on 1/19/2022 providing a brief update regarding the status of the parties' discussions. Ordered by Judge Mary Pat Thynge on 12/2/2021. (Taylor, Daniel) |
| Nov 23, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [92] Stipulation and Order to Amend the Case Schedule (Set/Reset Scheduling Order Deadlines: Opening Expert Reports due by 1/7/2022. Rebuttal Expert Reports due by 2/11/2022. Reply Expert Reports due by 3/11/2022). ORDERED by Judge Maryellen Noreika on 11/23/2021. (dlw) |
| Nov 23, 2021 | 92 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend the Case Schedule by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Nov 10, 2021 | 91 | Order Setting Mediation Conferences (4) Docket Text: ORDER Setting Mediation Conferences: A Telephone Conference is set for 12/2/2021 at 11:30 AM before Judge Mary Pat Thynge. Counsel for Plaintiffs shall initiate the call to chambers. Signed by Judge Mary Pat Thynge on 11/10/2021. (Taylor, Daniel) |
| Nov 5, 2021 | 89 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Supplemental Responses to Plaintiffs' First Set of Interrogatories (No. 7); (2) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s [CONFIDENTIAL - OUTSIDE COUNSEL EYES ONLY] Supplemental Responses to Plaintiffs' Second Set of Interrogatories (No. 9); and (3) Defendants' [HIGHLY CONFIDENTIAL] Second Supplemental Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 5, 2021 | 90 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Supplemental Response to Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s Interrogatory No. 8 and Second Supplemental Responses to Interrogatories Nos. 2, 4, and 5 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Oct 22, 2021 | 88 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' [HIGHLY CONFIDENTIAL] Supplemental Invalidity Contentions filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Oct 20, 2021 | 84 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order Regarding Authenticity and Admissibility of Documents by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Oct 20, 2021 | 85 | Stipulation (4) Docket Text: STIPULATION and [Proposed] Order Regarding Infringement and Discovery by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Oct 20, 2021 | 86 | SO ORDERED (3) Docket Text: SO ORDERED re [84] Stipulation and Order Regarding Authenticity and Admissibility of Documents. Signed by Judge Maryellen Noreika on 10/20/2021. (dlw) |
| Oct 20, 2021 | 87 | SO ORDERED (3) Docket Text: SO ORDERED re [85] Stipulation and Order Regarding Infringement and Discovery. Signed by Judge Maryellen Noreika on 10/20/2021. (dlw) |
| Oct 18, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [83] Stipulation and [Proposed] Order to Amend the Case Schedule. Set/Reset Scheduling Order Deadlines: (Fact Discovery completed by 11/5/2021., Opening Expert Reports due by 12/3/2021., Rebuttal Expert Reports due by 1/7/2022., Reply Expert Reports due by 2/11/2022., Expert Discovery due by 4/1/2022). ORDERED by Judge Maryellen Noreika on 10/18/2021. (mdb) |
| Oct 15, 2021 | 83 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend the Case Schedule by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Sep 29, 2021 | 82 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of [OUTSIDE COUNSEL EYES ONLY] Lupin Limited and Lupin Pharmaceuticals, Inc.'s Responses to Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited's Third Set of Interrogatories (Nos. 10-13) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Sep 23, 2021 | 81 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Responses to Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s Interrogatories (Nos. 1, 2, 3, 5, 7, and 9) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 15, 2021 | 80 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Lupin Limited and Lupin Pharmaceuticals, Inc.'s Notice of Rule 30(b)(6) Deposition of Plaintiffs Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 14, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [79] Stipulation and Order to Amend the Case Schedule (Set/Reset Scheduling Order Deadlines: Fact Discovery completed by 10/15/2021. Opening Expert Reports due by 11/12/2021. Rebuttal Expert Reports due by 12/17/2021. Reply Expert Reports due by 1/21/2022. Expert Discovery due by 3/11/2022). ORDERED by Judge Maryellen Noreika on 9/14/2021. (dlw) |
| Sep 14, 2021 | 79 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend the Case Schedule by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Sep 2, 2021 | 74 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Makrand Avachat on September 17, 2021 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 2, 2021 | 75 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Pramod Dahibhate on September 20, 2021 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 2, 2021 | 76 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Jason Gensburger on September 22, 2021 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 2, 2021 | 77 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Anirudha Kute on September 28, 2021 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 2, 2021 | 78 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Girij Singh on September 24, 2021 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Sep 1, 2021 | 73 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Objections to Plaintiffs' Rule 30(b)(6) Notice of Deposition filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Aug 30, 2021 | 72 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Third Set of Interrogatories filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Aug 27, 2021 | 69 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Supplemental Identification of Prior Art filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Aug 27, 2021 | 70 | Main Document (2) Docket Text: NOTICE to Take Deposition of Arbor Pharmaceuticals LLC Pursuant to Fed. R. Civ. P. 30(b)(6) on September 16, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Attachment A)(Bilson, David) |
| Aug 27, 2021 | 70 | Attachment A (3) |
| Aug 27, 2021 | 71 | Main Document (2) Docket Text: NOTICE to Take Deposition of Takeda Pharmaceutical Company Pursuant to Fed. R. Civ. P. 30(b)(6) on September 17, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Attachment A)(Bilson, David) |
| Aug 27, 2021 | 71 | Attachment A (3) |
| Aug 13, 2021 | 68 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Rule 30(b)(6) Notice of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc. filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Jul 20, 2021 | 66 | Transcript (48) Docket Text: Official Transcript of Markman Hearing Teleconference held on 07/14/2021 before Judge Maryellen Noreika. Court Reporter/Transcriber Deanna Warner,Email: warnerdeanna@gmail.com. Transcript may be viewed at the court public terminal or order/purchased through the Court Reporter/Transcriber before the deadline for Release of Transcript Restriction. After that date, it may be obtained through PACER. Redaction Request due 8/10/2021. Redacted Transcript Deadline set for 8/20/2021. Release of Transcript Restriction set for 10/18/2021. (dh) |
| Jul 20, 2021 | 67 | Memorandum and Order (7) Docket Text: MEMORANDUM ORDER REGARDING CLAIM CONSTRUCTION. Signed by Judge Maryellen Noreika on 7/20/2021. (dlw) |
| Jul 14, 2021 | N/A | Markman Hearing (0) Docket Text: Minute Entry for proceedings held before Judge Maryellen Noreika - Markman Hearing via zoom held on 7/14/2021. (Court Reporter Dale Hawkins.) (asw) |
| Jul 8, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: D.I. 61 through 67 have been deleted from the docket at the request of counsel. (dlw) |
| Jul 8, 2021 | 61 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Todd Brown on September 17, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jul 8, 2021 | 62 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Justin Kilby on September 17, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jul 8, 2021 | 63 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Allison Lowry on September 15, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jul 8, 2021 | 64 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Hiroki Sakamoto on September 24, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jul 8, 2021 | 65 | Notice to Take Deposition (2) Docket Text: NOTICE to Take Deposition of Yutake Tanoue on September 22, 2021 filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jun 29, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: The docket text of the 6/25/2021 Oral Order resetting the Markman hearing has been updated to reflect the correct year, 2021. The Markman hearing will take place beginning at 4:30 OM on 7/14/2021. (dlw) |
| Jun 25, 2021 | N/A | Set/Reset Scheduling Order Deadlines (0) Docket Text: ORAL ORDER re [57] Letter and RESETTING Scheduling Order Deadlines: IT IS HEREBY ORDERED that the Markman Hearing is RESET to begin at 4:30 PM on 7/14/2021 before Judge Maryellen Noreika and shall be held remotely. The Court is setting aside one hour for the hearing with the time split equally between the parties. Any slide presentations the parties wish to use shall be emailed (in PDF format) to MN_civil@ded.uscourts.gov no later than 24 hours prior to the hearing. Counsel shall meet and confer and provide agreed-upon connection credentials for the hearing (i.e. teleconference, videoconference) to this Court's judicial administrator no later than 7/9/2021. ORDERED by Judge Maryellen Noreika on 6/25/2021. (dlw) Modified on 6/29/2021 (dlw). |
| Jun 24, 2021 | 56 | Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from David A. Bilson regarding defendants' technology tutorial. (Bilson, David) |
| Jun 24, 2021 | 57 | Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Markman Hearing. (Silver, Daniel) |
| Jun 24, 2021 | 58 | Joint Claim Construction Brief (30) Docket Text: JOINT CLAIM CONSTRUCTION BRIEF filed by Takeda Pharmaceutical Company Limited, Arbor Pharmaceuticals, LLC. (Silver, Daniel) |
| Jun 24, 2021 | 59 | Appendix (30) Docket Text: Joint APPENDIX re [58] Joint Claim Construction Brief by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Silver, Daniel) |
| Jun 24, 2021 | 60 | Letter (1) Docket Text: Letter to The Honorable Maryellen Noreika from Daniel M. Silver, Esq. regarding Plaintiff's Technology Tutorial. (Silver, Daniel) |
| Jun 21, 2021 | 54 | Stipulation (3) Docket Text: STIPULATION and [Proposed] Order to Amend Case Schedule by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Jun 21, 2021 | 55 | SO ORDERED (3) Docket Text: SO ORDERED re [54] Stipulation and Order to Amend Case Schedule (Set/Reset Scheduling Order Deadlines: Amended Pleadings due by 9/7/2021. Fact Discovery completed by 9/29/2021. Opening Expert Reports due by 10/27/2021. Rebuttal Expert Reports due by 12/1/2021. Reply Expert Reports due by 1/5/2022. Expert Discovery due by 2/24/2022. Joinder of Parties due by 9/7/2021). Signed by Judge Maryellen Noreika on 6/21/2021. (dlw) |
| Jun 17, 2021 | 53 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Sur-Reply Claim Construction Brief filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jun 9, 2021 | 52 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Reply Claim Construction Brief filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| May 28, 2021 | 51 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs Objections and Responses to Defendants Lupin Limiteds and Lupin Pharmaceuticals, Inc.s Second Set of Interrogatories (Nos. 9-10) and (2) Plaintiffs Objections and Responses to Defendants Lupin Limiteds and Lupin Pharmaceuticals, Inc.s Second Set of Requests for Production of Documents and Things (Nos. 86-90) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| May 25, 2021 | 50 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Supplemental Objections and Responses to Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s Interrogatory No. 4 filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| May 20, 2021 | 49 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 47-55) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| May 19, 2021 | 48 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants' Responsive Claim Construction Brief filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Apr 29, 2021 | N/A | CORRECTING ENTRY: (0) Docket Text: CORRECTING ENTRY: At the request of counsel, D.I. 47 has been replaced on the docket and the docket text updated to reflect service of the second set of interrogatories. (dlw) |
| Apr 28, 2021 | 47 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Set of Interrogatories (Nos. 9-10); and (2) Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Second Set of Requests for Production of Documents and Things (Nos. 86-90) filed by Lupin Limited, Lupin Pharmaceuticals, Inc. (Bilson, David) Modified on 4/29/2021 (dlw). (Main Document 47 replaced on 4/29/2021) (dlw). |
| Apr 22, 2021 | 46 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Opening Claim Construction Brief filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Apr 20, 2021 | 45 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Second Set of Requests for the Production of Documents and Things (Nos. 47-55) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Apr 8, 2021 | 44 | Claim Construction Chart (6) Docket Text: JOINT CLAIM Construction Chart by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Silver, Daniel) Modified on 4/8/2021 (dlw). |
| Mar 17, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [43] Stipulation and Order to Clarify Scheduling Order (Joint Claim Construction Chart due by April 8, 2021). ORDERED by Judge Maryellen Noreika on 3/17/2021. (dlw) |
| Mar 16, 2021 | 43 | Stipulation (2) Docket Text: STIPULATION and [Proposed] Order to Clarify Scheduling Order by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Feb 25, 2021 | 42 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited and Lupin Pharmaceuticals, Inc.'s Initial Identification of Proposed Claim Terms for Construction filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Feb 12, 2021 | 41 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants' Initial Invalidity Contentions; and (2) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s [CONFIDENTIAL-OUTSIDE COUNSEL EYES ONLY] Responses to Plaintiffs' Second Set of Interrogatories (No. 9) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Jan 14, 2021 | 40 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Lupin Limiteds and Lupin Pharmaceuticals, Inc.s First Set of Interrogatories (Nos. 1-8) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Jan 13, 2021 | 39 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Plaintiffs' Initial Infringement Contentions Against Lupin, and (2) Plaintiffs' Second Set of Interrogatories filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Dec 28, 2020 | 37 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of (1) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' First Set of Interrogatories (Nos. 1-8); and (2) Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Responses to Plaintiffs' First Set of Requests for the Production of Documents and Things (Nos. 1-46) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Dec 28, 2020 | 38 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' Objections and Responses to Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-85) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Dec 15, 2020 | 35 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Core Technical Documents filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Dec 15, 2020 | 36 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s First Set of Interrogatories (Nos. 1-9) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 25, 2020 | 34 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs' First Set of Interrogatories filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Nov 24, 2020 | 32 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Limited's and Lupin Pharmaceuticals, Inc.'s First Set of Requests for Production of Documents and Things (Nos. 1-85) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 24, 2020 | 33 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs First Set of Requests for the Production of Documents and Things (Nos. 1-46) filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Nov 20, 2020 | 31 | Protective Order (26) Docket Text: STIPULATED PROTECTIVE ORDER. Signed by Judge Maryellen Noreika on 11/20/2020. (dlw) |
| Nov 19, 2020 | 30 | Proposed Order (26) Docket Text: PROPOSED ORDER // Stipulated Protective Order by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) Modified on 11/20/2020 (dlw). |
| Nov 16, 2020 | 29 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Paragraph 4 Disclosures Identifying Lupins Accused Product and Plaintiffs Asserted Patents filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Nov 12, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [26] STIPULATION TO EXTEND TIME to submit a proposed Protective Order to November 19, 2020. ORDERED by Judge Maryellen Noreika on 11/12/2020. (dlw) |
| Nov 12, 2020 | 26 | Stipulation to EXTEND Time (1) Docket Text: STIPULATION TO EXTEND TIME to submit a proposed Protective Order to November 19, 2020 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Nov 12, 2020 | 27 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Disclosures Pursuant to Paragraph 3 of the Delaware Default Standard for Discovery filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 12, 2020 | 28 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Initial Paragraph 3 Disclosures Regarding Custodians and Non-Custodial Data Sources filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Nov 2, 2020 | 24 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Defendants Lupin Ltd. and Lupin Pharmaceuticals, Inc.'s Initial Disclosures Pursuant to Fed. R. Civ. P. 26(a)(1) filed by Lupin Limited, Lupin Pharmaceuticals, Inc..(Bilson, David) |
| Nov 2, 2020 | 25 | Notice of Service (2) Docket Text: NOTICE OF SERVICE of Plaintiffs Rule 26(a)(1) Initial Disclosures filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Joyce, Alexandra) |
| Oct 30, 2020 | 23 | Order Setting Teleconference (4) Docket Text: ORDER Setting Teleconference: A Telephone Conference is set for 12/11/2020 at 9:30 AM Eastern Time with Judge Mary Pat Thynge to discuss ADR. Plaintiffs' counsel to initiate the call. Signed by Judge Mary Pat Thynge on 10/30/20. (cak) |
| Oct 27, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [22] STIPULATION TO EXTEND deadline for the parties to make their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and to submit a proposed form of Protective Order to November 2, 2020 and November 12, 2020, respectively. ORDERED by Judge Maryellen Noreika on 10/27/2020. (dlw) |
| Oct 26, 2020 | 22 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME deadline for the parties to make their initial disclosures pursuant to Federal Rule of Civil Procedure 26(a)(1) and to submit a proposed form of Protective Order to November 2, 2020 and November 12, 2020, respectively. - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Bilson, David) |
| Oct 21, 2020 | N/A | Case Referred to Mediation (0) Docket Text: CASE REFERRED to Chief Magistrate Judge Mary Pat Thynge for Mediation. Please see Standing Order dated January 20, 2016, regarding disclosure of confidential ADR communications. A link to the standing order is provided here for your convenience at https://www.ded.uscourts.gov/sites/ded/files/forms/StandingOrderforADR-Mediation.pdf (cak) |
| Oct 19, 2020 | 21 | Scheduling Order (13) Docket Text: SCHEDULING ORDER: Case referred to the Magistrate Judge for the purpose of exploring ADR. Joinder of Parties due by 7/23/2021. Amended Pleadings due by 7/23/2021. Fact Discovery completed by 9/17/2021. Opening Expert Reports due by 10/15/2021. Rebuttal Expert Reports due by 11/19/2021. Reply Expert Reports due by 12/17/2021. Expert Discovery due by 2/18/2022. Claim Construction Opening Brief served by 4/22/2021. Claim Construction Answering Brief served by 5/19/2021. Claim Construction Reply Brief served by 6/9/2021. Claim Construction Surreply Brief served by 6/17/2021. Joint Claim Construction Brief filed by 6/24/2021. A Markman Hearing is set for 7/14/2021 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A Pretrial Conference is set for 5/2/2022 at 10:00 AM in Courtroom 4A before Judge Maryellen Noreika. A 5-day Bench Trial is set for 5/16/2022 at 09:30 AM in Courtroom 4A before Judge Maryellen Noreika. Signed by Judge Maryellen Noreika on 10/19/2020. (dlw) |
| Oct 14, 2020 | 20 | Main Document (13) Docket Text: PROPOSED ORDER // Scheduling Order by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: # (1) Letter to The Honorable Maryellen Noreika from Daniel M. Silver re Proposed Scheduling Order)(Silver, Daniel) Modified on 10/15/2020 (dlw). |
| Oct 14, 2020 | 20 | Letter to The Honorable Maryellen Noreika from Daniel M. Silver re Proposed Sch (3) |
| Sep 29, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [19] STIPULATION TO EXTEND TIME for the Parties to Submit a Proposed Scheduling Order to October 14, 2020. ORDERED by Judge Maryellen Noreika on 9/29/2020. (dlw) |
| Sep 28, 2020 | 19 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME the Deadline for the Parties to Submit a Proposed Scheduling Order to October 14, 2020 - filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Joyce, Alexandra) |
| Aug 31, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jeremiah S. Helm for Lupin Limited, for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 31, 2020 | N/A | Oral Order (0) Docket Text: ORAL ORDER - IT IS HEREBY ORDERED that the parties shall confer regarding proposed dates in the scheduling order and shall submit a proposed order, including a proposal for the length and timing of trial, to the Court no later than thirty (30) days from the date of this Order. The parties are to use the Court's form scheduling order, which is posted at http://www.ded.uscourts.gov (see Chambers, Judge Noreika, Forms). If there are disputes or issues that the Court needs to address in the proposed scheduling order, the parties shall direct the Court to the paragraph numbers in which those appear in a cover letter to the Court. ORDERED by Judge Maryellen Noreika on 8/31/2020. (dlw) |
| Aug 28, 2020 | 17 | Answer to Counterclaim (6) Docket Text: ANSWER to [12] Answer to Complaint, Counterclaim by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited.(Silver, Daniel) |
| Aug 26, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Christopher P. Hill for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 19, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [16] MOTION for Pro Hac Vice Appearance of Attorney Christopher P. Hill filed by Arbor Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 8/19/2020. (dlw) |
| Aug 18, 2020 | 16 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Christopher P. Hill - filed by Arbor Pharmaceuticals, LLC. (Attachments: # (1) Certification of Counsel)(Silver, Daniel) |
| Aug 18, 2020 | 16 | Certification of Counsel (1) |
| Aug 14, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys William F. Cavanaugh and Zhiqiang Liu for Takeda Pharmaceutical Company Limited added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Aug 13, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [15] MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu filed by Takeda Pharmaceutical Company Limited, Arbor Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 8/13/2020. (dlw) |
| Aug 11, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Jonathan E. Bachand for Lupin Limited,for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 11, 2020 | 15 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William F. Cavanaugh, Jr. and Zhiqiang Liu - filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: # (1) Certifications for William F. Cavanaugh, Jr. and Zhiqiang Liu)(Silver, Daniel) |
| Aug 11, 2020 | 15 | Certifications for William F. Cavanaugh, Jr. and Zhiqiang Liu (2) |
| Aug 10, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [14] MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Jeremiah S. Helm filed by Lupin Limited, Lupin Pharmaceuticals, Inc. ORDERED by Judge Maryellen Noreika on 8/10/2020. (dlw) |
| Aug 10, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney William R. Zimmerman for Lupin Limited, for Lupin Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Aug 7, 2020 | 12 | Answer to Complaint (19) Docket Text: ANSWER to [1] Complaint, Affirmative Defenses, and, COUNTERCLAIM against Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited by Lupin Pharmaceuticals, Inc., Lupin Limited.(Phillips, John) Modified on 8/11/2020 (dlw). |
| Aug 7, 2020 | 13 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Lupin Ltd. for Lupin Pharmaceuticals, Inc.; Corporate Parent No parent corporations for Lupin Limited filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Aug 7, 2020 | 14 | Main Document (1) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney William Zimmerman, Jonathan E. Bachand and Jeremiah S. Helm - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Attachments: # (1) Zimmerman Pro Hac Certification, # (2) Bachand Pro Hac Certification, # (3) Helm Pro Hac Certification)(Bilson, David) |
| Aug 7, 2020 | 14 | Zimmerman Pro Hac Certification (1) |
| Aug 7, 2020 | 14 | Bachand Pro Hac Certification (1) |
| Aug 7, 2020 | 14 | Helm Pro Hac Certification (1) |
| Jul 16, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [8] STIPULATION TO EXTEND TIME for Lupin defendants to answer, move or otherwise respond to the Complaint (D.I. 1) to August 19, 2020 (Set/Reset Answer Deadlines: Lupin Limited answer due 8/19/2020; Lupin Pharmaceuticals, Inc. answer due 8/19/2020). ORDERED by Judge Maryellen Noreika on 7/16/2020. (dlw) |
| Jul 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorneys Bruce M. Wexler and Chad J. Peterman for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (kmd) |
| Jul 16, 2020 | N/A | Add Attorneys Pro Hac Vice (0) Docket Text: Pro Hac Vice Attorney Michael F. Werno for Arbor Pharmaceuticals, LLC added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (myr) |
| Jul 15, 2020 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Maryellen Noreika. Please include the initials of the Judge (MN) after the case number on all documents filed. (rjb) |
| Jul 15, 2020 | N/A | SO ORDERED (0) Docket Text: SO ORDERED re [11] MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, and Michael F. Werno filed by Takeda Pharmaceutical Company Limited, Arbor Pharmaceuticals, LLC. ORDERED by Judge Maryellen Noreika on 7/15/2020. (dlw) |
| Jul 15, 2020 | 11 | Main Document (2) Docket Text: MOTION for Pro Hac Vice Appearance of Attorney Bruce M. Wexler, Chad J. Peterman, and Michael F. Werno - filed by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: # (1) Certifications for Bruce Wexler, Chad J. Peterman, and Michael F. Werno)(Silver, Daniel) |
| Jul 15, 2020 | 11 | Certifications for Bruce Wexler, Chad J. Peterman, and Michael F. Werno (3) |
| Jul 14, 2020 | 8 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME for Lupin to answer, move or otherwise respond to the Complaint (D.I. 1) to August 19, 2020 - filed by Lupin Limited, Lupin Pharmaceuticals, Inc.. (Phillips, John) |
| Jul 14, 2020 | 9 | Main Document (2) Docket Text: DECLARATION of Service regarding Defedant Lupin Limited made on July 8, 2020 by Arbor Pharmaceuticals, LLC, Takeda Pharmaceutical Company Limited. (Attachments: # (1) Exhibit A-B)(Silver, Daniel) Modified on 7/16/2020 (dlw). |
| Jul 14, 2020 | 9 | Exhibit A-B (5) |
| Jul 14, 2020 | 10 | Summons Returned Executed (2) Docket Text: SUMMONS Returned Executed by Takeda Pharmaceutical Company Limited, Arbor Pharmaceuticals, LLC. Lupin Pharmaceuticals, Inc. served on 7/8/2020, answer due 7/29/2020. (Silver, Daniel) |
| Jul 8, 2020 | 1 | Main Document (11) Docket Text: COMPLAINT - filed against Lupin Limited, Lupin Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number ADEDC-3047193.) - filed by Takeda Pharmaceutical Company Limited, Arbor Pharmaceuticals, LLC. (Attachments: # (1) Exhibit A-C, # (2) Civil Cover Sheet) (lak) |
| Jul 8, 2020 | 1 | Exhibit A-C (52) |
| Jul 8, 2020 | 1 | Civil Cover Sheet (1) |
| Jul 8, 2020 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lak) |
| Jul 8, 2020 | 3 | ANDA Form (2) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/24/2020. Date of Expiration of Patent: See attached.Thirty Month Stay Deadline: 11/24/2022. (lak) |
| Jul 8, 2020 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,157,584 ;7,572,920 ;9,066,936. (lak) |
| Jul 8, 2020 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Arbor Pharmaceuticals, Inc., Corporate Parent KKR Crown Investors LP, Corporate Parent KKR & Co. Inc. for Arbor Pharmaceuticals, LLC filed by Arbor Pharmaceuticals, LLC. (lak) |
| Jul 8, 2020 | 6 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: No Parents or Affiliates Listed filed by Takeda Pharmaceutical Company Limited. (lak) |
| Jul 8, 2020 | 7 | Summons Issued - Electronic (2) Docket Text: Summonses Issued as to Lupin Limited and Lupin Pharmaceuticals, Inc. on 7/8/2020. (please complete the top portion of the form and print out for use/service). (lak) |
| Jul 8, 2020 | 1 | Complaint* (1) |
